Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

511.08
Delayed Data
As of Jul 02
 +4.57 / +0.90%
Today’s Change
295.76
Today|||52-Week Range
544.00
+24.58%
Year-to-Date

Today’s Trading

Previous close506.51
Today’s open509.50
Day’s range505.29 - 512.50
Volume374,932
Average volume (3 months)762,407
Market cap$52.7B
Dividend yield--
Data as of 4:00pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-19.42%
Earnings growth (this year)+10.78%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+33.96%
P/E ratio163.8
Price/Sales16.50
Price/Book20.55

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...+0.27+0.23%
QQuintiles Transnatio...-0.17-0.23%
ISISIsis Pharmaceuticals...-1.03-1.80%
ICLRICON PLC-0.44-0.65%
Data as of 4:04pm ET, 07/02/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)$2.79
Annual revenue (last year)$2.8B
Annual profit (last year)$348.1M
Net profit margin12.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers